Bridgebio Pharma, Inc. · NASDAQ:BBIO
Janus Henderson Group PLC reported a 5.70% stake in Bridgebio Pharma, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
Janus Henderson Group PLC reported a 5.70% stake in Bridgebio Pharma, Inc., 11,000,457 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 5.70%
- Shares
- 11,000,457
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 5.70% | 11,000,457 |
Source
Related
- Bridgebio Pharma, Inc.
- Janus Henderson Group PLC
- Bridgebio Pharma, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Form 4 · Kumar Neil · Sep 21, 2026
- Form 4 · Kumar Neil · Aug 20, 2026
- Form 4 · Kumar Neil · Aug 18, 2026
- Form 4 · Trimarchi Thomas · Aug 18, 2026
- Form 4 · Apuli Maricel · Aug 18, 2026